EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Retraction Notice: “YTHDF1-mediated sphingosine kinase 2 upregulation alleviates bupivacaine-induced neurotoxicity via the PI3K/AKT axis”

Human & Experimental Toxicology · 2026-05 · 45

DOI: 10.1177/09603271261452720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human & Experimental Toxicology, online erschienen am 20.05.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Retraction Notice: “YTHDF1-mediated sphingosine kinase 2 upregulation alleviates bupivacaine-induced neurotoxicity via the PI3K/AKT axis”. Human & Experimental Toxicology, 45. https://doi.org/10.1177/09603271261452720

Vancouver

Retraction Notice: “YTHDF1-mediated sphingosine kinase 2 upregulation alleviates bupivacaine-induced neurotoxicity via the PI3K/AKT axis”. Human & Experimental Toxicology. 2026;45. doi:10.1177/09603271261452720

BibTeX
@article{euvimed2026,
  title = {Retraction Notice: “YTHDF1-mediated sphingosine kinase 2 upregulation alleviates bupivacaine-induced neurotoxicity via the PI3K/AKT axis”},
  journal = {Human & Experimental Toxicology},
  year = {2026},
  volume = {45},
  doi = {10.1177/09603271261452720}
}
Kostenlos starten →